The Delhi government has set up two control rooms to monitor and manage the supply of "COVID-19 management drugs" amid a massive rise in coronavirus cases in the national capital.
Delhi on Sunday recorded the biggest jump in its daily COVID-19 tally with 25,462 fresh cases, while the positivity rate shot up to 29.74 per cent -- meaning almost every third sample being tested in the city is turning out to be positive.
In an order, the government's Drugs Control Department said that the step has been taken to address reports of "acute shortage of COVID-19 management drugs due to a sudden rise in COVID-19 cases in Delhi".
"In view to counter this situation and to facilitate the general public at large, the Drugs Control Department. Govt of NCT of Delhi has set up two control rooms," the order dated April 13 said.
For East, North East, South, Central, New Delhi and North districts, the Karkardooma Head Office will serve as the control room and operate the helpline number -- 011-22393705, according to the order.
The Lawrence Road Zonal Office is the second control room and it will serve the North West, South West, and West districts. It can be reached at helpline number-- 011-27100164, it said.
The department said that manufacturing companies can also be reached through their individual helpline numbers.
"Every attempt is being made to make available COVID management drugs in all major hospitals and company distribution outlets for which companies have also provided their helpline numbers, who can be approached along with documentary details of the hospitalization of patient, hospital prescription, COVID positive report and Aadhar card," it said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU